The United States is grappling with a significant resurgence of measles, recording 2,318 confirmed infections in 2026, marking the highest annual total in 35 years. This spike in cases has raised alarms among public health officials, particularly given the demographics of those affected. A substantial 69% of these cases occurred in individuals aged 19 or younger, with children under five years old accounting for one-fifth of all infections. Critically, 93% of all confirmed measles cases were among unvaccinated individuals, highlighting the direct link between vaccination status and disease susceptibility.
The national kindergarten measles, mumps, and rubella (MMR) vaccination coverage currently stands at 92.5%. This figure falls below the 95% threshold widely recognized as necessary to achieve effective herd immunity, a level where enough of the population is immune to prevent the spread of the disease to those who cannot be vaccinated, such as infants or individuals with compromised immune systems. The gap between current vaccination rates and the required herd immunity level suggests a vulnerability that public health authorities are working to address, emphasizing the importance of routine childhood immunizations.
Globally, the Democratic Republic of the Congo has reported a severe Ebola outbreak. Following a comprehensive data review, nearly 3,000 confirmed cases have been identified, resulting in more than 1,269 deaths. This outbreak underscores the persistent threat of infectious diseases in vulnerable regions and the critical need for rapid response and robust public health infrastructure to contain such epidemics.
Domestically, federal health agencies have been actively investigating several foodborne illness outbreaks. The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) expanded an investigation into a cyclospora outbreak linked to shredded iceberg lettuce. The contaminated lettuce, imported from central Mexico, has been implicated in 1,947 cases and 98 hospitalizations across nine states. Fortunately, no deaths have been reported in connection with this outbreak. The affected lettuce was promptly recalled from the market, and the implicated processing facility in Mexico was temporarily closed as part of the ongoing investigation to prevent further contamination.
In a separate food safety incident, Midwest Poultry Services initiated a recall of nearly 1.6 million dozen eggs due to a potential Salmonella risk. Salmonella infections can cause fever, diarrhea, nausea, vomiting, and abdominal pain, and can be serious or even fatal in young children, frail or elderly people, and individuals with weakened immune systems. The large scale of this recall highlights the continuous vigilance required within the food industry to ensure consumer safety and prevent widespread illness.
Legal and regulatory developments in the pharmaceutical sector have also drawn attention. A federal judge dismissed a shareholder lawsuit against Abbott Laboratories concerning its 2022 powdered infant-formula recall. Judge Steven Seeger ruled that the shareholders had not presented sufficient evidence to demonstrate that the company intended to deceive them regarding issues at its Sturgis, Michigan, plant, which had led to a significant product recall and exacerbated a national infant formula shortage.
In broader pharmaceutical policy, Merck has signed agreements covering an experimental HIV pill in 129 countries, aiming to expand access to potential new treatments for the virus globally. Concurrently, the FDA has made several decisions regarding pharmacy compounding, including excluding the peptide emideltide from compounding lists while recommending Semax for inclusion. These decisions reflect the agency’s ongoing efforts to regulate compounded medications, ensuring their safety and efficacy. Separately, a Virginia federal judge ordered the FDA to reassess special licensing requirements for prescribing mifepristone, a medication used for medication abortion, signaling continued judicial scrutiny of the agency’s regulatory authority over certain prescription drugs.
Why it matters in Greer
The array of national and international health developments outlined above has direct and indirect implications for the community of Greer. The national measles surge, driven by declining vaccination rates, underscores the importance of maintaining high immunization coverage within local populations, particularly for students attending Greenville County Schools (GCS). Food safety incidents, such as the cyclospora outbreak and the egg recall, highlight the need for robust local food inspection practices and consumer awareness, impacting residents who rely on grocery stores and restaurants throughout Greer. Furthermore, pharmaceutical policy changes and litigation, like the Abbott Laboratories lawsuit and the FDA’s decisions on drug prescribing, influence the availability, cost, and safety of medications for all residents, including employees of major employers like BMW Manufacturing Co. and those served by local healthcare providers. These broader trends reinforce the continuous need for public health vigilance and informed decision-making within Greer and the wider Upstate South Carolina region.
